David Tapolczay - Nov 18, 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
Chief Executive Officer, Director
Signature
/s/ David Tapolczay
Stock symbol
CDT
Transactions as of
Nov 18, 2024
Transactions value $
$77,196
Form type
4
Date filed
11/20/2024, 04:30 PM
Previous filing
Apr 24, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDT Stock Option (Right to Buy) Award $77.2K +840K $0.09 840K Nov 18, 2024 Common Stock 840K $0.09 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan.
F2 The Options vest as follows: (i) 50% on the grant date and (ii) 50% in equal annual installments on the first three anniversaries of the grant date.